These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Guidelines for the use of thrombolytic therapy. Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. Ludlam CA; Bennett B; Fox KA; Lowe GD; Reid AW Blood Coagul Fibrinolysis; 1995 May; 6(3):273-85. PubMed ID: 7654941 [No Abstract] [Full Text] [Related]
24. Life-threatening anaphylactoid shock caused by recombinant tissue plasminogen activator. Wang CT; Lin FC; Khor GT; Chen CH; Huang P Am J Emerg Med; 2012 Jan; 30(1):253.e1-2. PubMed ID: 21109385 [TBL] [Abstract][Full Text] [Related]
25. New fibrinolytic agents for MI: as effective as current agents, but easier to administer. Ellis K; Brener S Cleve Clin J Med; 2004 Jan; 71(1):20, 23-5, 29-30 passim. PubMed ID: 14740966 [TBL] [Abstract][Full Text] [Related]
26. tPA in daily clinical practice. Nighoghossian N Stroke; 2003 May; 34(5):1106-13. PubMed ID: 12733503 [No Abstract] [Full Text] [Related]
27. Comparison of tissue plasminogen activator administration management between Telestroke Network hospitals and academic stroke centers: the Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany. Audebert HJ; Kukla C; Vatankhah B; Gotzler B; Schenkel J; Hofer S; Fürst A; Haberl RL Stroke; 2006 Jul; 37(7):1822-7. PubMed ID: 16763192 [TBL] [Abstract][Full Text] [Related]
28. Thrombolytic-associated coagulopathy and management dilemmas: a review of two cases. Illoh OC; Illoh K Blood Coagul Fibrinolysis; 2008 Sep; 19(6):605-7. PubMed ID: 18685447 [TBL] [Abstract][Full Text] [Related]
29. [Upper airway obstruction by angioedema following thrombolytic therapy with recombinant tissue plasminogen activator]. García-Jiménez A; Iriarte Sotés P; Fernández González CJ; Garrote Freire A; González Tutor J An Med Interna; 2003 Mar; 20(3):163-4. PubMed ID: 12756909 [No Abstract] [Full Text] [Related]
30. The results of arterial thrombolysis. Kroese AJ; Staxrud LE Ann Chir Gynaecol; 1995; 84(4):350-3. PubMed ID: 8687078 [No Abstract] [Full Text] [Related]
31. [Thrombolysis in capsular warning syndrome]. González Hernández A; Fabre Pi O; López Fernández JC; Díaz Nicolás S Med Clin (Barc); 2010 May; 134(13):612-3. PubMed ID: 19359006 [No Abstract] [Full Text] [Related]
32. [Future developments in thrombolytic therapy]. Bode C; Runge MS Z Kardiol; 1993; 82 Suppl 2():187-90. PubMed ID: 8328201 [TBL] [Abstract][Full Text] [Related]
33. [Coronary thrombolytic agents and their characteristics]. Yoshinaga M; Kambara H Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):775-81. PubMed ID: 12436615 [No Abstract] [Full Text] [Related]
34. Intravenous thrombolytic therapy for acute ischemic stroke. Wechsler LR N Engl J Med; 2011 Jun; 364(22):2138-46. PubMed ID: 21631326 [No Abstract] [Full Text] [Related]
35. Pharmacologic therapies in the treatment of peripheral vascular disease: clinical experience with reteplase, a third-generation thrombolytic. Laird JR J Invasive Cardiol; 2000 Mar; 12 Suppl B():27B-32B. PubMed ID: 10731297 [No Abstract] [Full Text] [Related]